| 2023-07-25 | -9.9% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-10-26 | +9.4% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-30 | +8.3% | earnings | Seeking Alpha | Merit Medical Systems Non-GAAP EPS of $0.92 beats by $0.09, revenue of $384.2M beats by $12.46M |
| 2025-10-30 | +8.3% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-10-26 | +8.3% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-07-29 | +7.7% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-08-01 | +7.3% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2022-04-27 | -6.5% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-01-08 | -6.4% | earnings | Seeking Alpha | Merit Medical Systems reports Preliminary Q4 results |
| 2026-01-08 | -6.4% | earnings | Seeking Alpha | Merit Medical names F. Ann Millner Board of chair and reports preliminary Q4 2025 revenue |
| 2026-01-08 | -6.4% | legal | SEC EDGAR | MMSI 8-K: 2.02, 5.02, 7.01 (SEC Filing) |
| 2023-12-06 | +5.9% | legal | SEC EDGAR | MMSI 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-02-25 | -5.6% | earnings | Seeking Alpha | Merit Medical Systems, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-25 | -5.6% | earnings | Seeking Alpha | Merit Medical projects 6%-8% revenue growth for 2026 while divesting DualCap and strengthening global platforms |
| 2026-02-25 | -5.6% | earnings | Seeking Alpha | Merit Medical Systems, Inc. (MMSI) Q4 2025 Earnings Call Transcript |
| 2024-02-28 | -5.5% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-10-30 | +5.1% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-31 | +4.7% | earnings | Seeking Alpha | Merit Medical Systems, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-10-31 | +4.7% | earnings | Seeking Alpha | Merit Medical targets $175M free cash flow in 2025 with updated guidance and new CEO at helm |
| 2025-10-31 | +4.7% | earnings | Seeking Alpha | Merit Medical Systems, Inc. (MMSI) Q3 2025 Earnings Call Transcript |
| 2022-02-24 | +4.6% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-02-24 | -4.5% | earnings | Seeking Alpha | Merit Medical Systems Non-GAAP EPS of $1.04 beats by $0.09, revenue of $393.9M beats by $2.98M |
| 2026-02-24 | -4.5% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-09-09 | -4.4% | news | Seeking Alpha | Merit Medical Has To Rebuild Some Confidence In The Growth Story |
| 2025-07-31 | +4.2% | earnings | Seeking Alpha | Merit Medical Systems, Inc. 2025 Q2 - Results - Earnings Call Presentation |
| 2025-07-31 | +4.2% | earnings | Seeking Alpha | Merit Medical Systems outlines 2025 revenue guidance of 10–11% growth and updates WRAPSODY reimbursement timeline |
| 2025-07-31 | +4.2% | earnings | Seeking Alpha | Merit Medical Systems, Inc. (MMSI) Q2 2025 Earnings Call Transcript |
| 2025-01-14 | +4.2% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-10-22 | -4.1% | legal | SEC EDGAR | MMSI 8-K: 5.02 and (SEC Filing) |
| 2024-04-30 | +4.0% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-04-20 | -3.5% | earnings | MT Newswires | Barrington Trims Price Target on Merit Medical Systems to $107 From $109, Keeps Outperform Rating |
| 2026-04-20 | -3.5% | M&A | Simply Wall St. | Merit Medical Systems Acquisition Expands Oncology Portfolio And Investor Considerations |
| 2023-04-26 | +3.1% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2021-10-28 | -3.0% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-07-30 | +2.9% | earnings | Seeking Alpha | Merit Medical Systems Non-GAAP EPS of $1.01 beats by $0.16, revenue of $382.5M beats by $7.47M |
| 2025-07-30 | +2.9% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-07-07 | +2.7% | earnings | Seeking Alpha | Merit Medical names Martha Aronson as CEO and announces prelim revenue in the range of $380M to $384M |
| 2026-04-01 | -2.6% | M&A | Seeking Alpha | Merit Medical acquires View Point Medical |
| 2023-06-08 | -2.6% | legal | SEC EDGAR | MMSI 8-K: 1.01, 2.02, 5.02, 7.01 (SEC Filing) |
| 2023-06-08 | -2.6% | legal | SEC EDGAR | MMSI 8-K: 1.01 and 2.03 (SEC Filing) |
| 2025-02-25 | -2.5% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-10-10 | -2.5% | legal | SEC EDGAR | MMSI 8-K: 5.02 (SEC Filing) |
| 2023-02-22 | +2.4% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-01-08 | +2.2% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-02 | -2.2% | executive | Stock Titan | Merit Medical (NASDAQ: MMSI) grants stock awards to chief legal officer - Stock Titan |
| 2026-03-02 | -2.2% | executive | Stock Titan | Merit Medical (MMSI) COO awarded RSUs and surrenders shares for taxes - Stock Titan |
| 2024-05-16 | -2.2% | legal | SEC EDGAR | MMSI 8-K: 5.02, 8.01 (SEC Filing) |
| 2022-07-27 | +2.1% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-12-08 | -2.0% | legal | SEC EDGAR | MMSI 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2022-09-01 | -2.0% | legal | SEC EDGAR | MMSI 8-K: 5.02 and (SEC Filing) |
| 2025-11-18 | -2.0% | news | Seeking Alpha | Merit Medical Systems: A Better Setup Here |
| 2025-04-24 | -1.9% | earnings | Seeking Alpha | Merit Medical Systems Non-GAAP EPS of $0.86 beats by $0.11, revenue of $355.4M beats by $2.83M |
| 2025-04-24 | -1.9% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-10 | +1.9% | news | Stock Titan | Merit Medical Begins Clinical Trial for Groundbreaking Premature Baby Heart Treatment - Stock Titan |
| 2025-02-26 | -1.9% | earnings | Seeking Alpha | Merit Medical Systems, Inc. (MMSI) Q4 2024 Earnings Call Transcript |
| 2026-04-15 | -1.7% | news | Zacks | Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now |
| 2025-07-11 | -1.6% | legal | SEC EDGAR | MMSI 8-K: 2.02, 5.02 (SEC Filing) |
| 2021-11-24 | -1.5% | legal | SEC EDGAR | MMSI 8-K: 8.01 and (SEC Filing) |
| 2026-04-17 | -1.4% | news | Insider Monkey | BTIG Adjusts Merit Medical Systems, Inc. (MMSI) Model Ahead of Medicare Payment Changes |
| 2026-04-18 | -1.4% | news | StockStory | 3 Small-Cap Stocks We Keep Off Our Radar |
| 2021-06-23 | +1.3% | legal | SEC EDGAR | MMSI 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-04-08 | -1.3% | news | Zacks | Here's Why Merit Medical (MMSI) is a Strong Growth Stock |
| 2026-04-02 | -1.2% | legal | Stock Titan | MMSI SEC Filings - Merit Med Sys Inc 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-04-02 | -1.2% | news | Stock Titan | Merit Medical schedules April 30 call after first-quarter results - Stock Titan |
| 2026-04-02 | -1.2% | news | Stock Titan | Merit Medical (NASDAQ: MMSI) director Fred Lampropoulos files Form 4 with no trades - Stock Titan |
| 2026-04-13 | +1.1% | news | Stock Titan | [8-K] MERIT MEDICAL SYSTEMS INC Reports Material Event - Stock Titan |
| 2024-05-21 | -1.1% | legal | SEC EDGAR | MMSI 8-K: 1.01, 5.02, 5.03, 5.07, 8.01 (SEC Filing) |
| 2023-02-28 | -1.0% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-16 | +1.0% | earnings | Seeking Alpha | Merit Medical: A Success Story That Keeps Getting Better |
| 2025-11-14 | -0.9% | news | Seeking Alpha | Merit pivots to new commercial strategy for Wrapsody dialysis device after Medicare delay |
| 2026-03-16 | -0.9% | news | Stock Titan | New esophageal stent uses anti-migration design for cancer-related narrowing - Stock Titan |
| 2026-01-14 | -0.7% | news | Seeking Alpha | Merit Medical Systems, Inc. (MMSI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2022-04-22 | -0.7% | legal | SEC EDGAR | MMSI 8-K: 5.02, 8.01 (SEC Filing) |
| 2026-02-23 | +0.6% | earnings | Seeking Alpha | Merit Medical Systems Q4 2025 Earnings Preview |
| 2025-10-15 | +0.6% | M&A | Seeking Alpha | Merit Medical to acquire C2 CryoBalloon technology for $22M |
| 2025-05-22 | -0.5% | news | Seeking Alpha | Merit Medical Systems: A Quality Business Judged On Its Merits |
| 2026-04-07 | -0.5% | M&A | Insider Monkey | Merit Medical Systems (MMSI) Acquires View Point Medical for $140M |
| 2026-04-07 | -0.5% | news | Zacks | Merit Medical (MMSI) is a Top-Ranked Value Stock: Should You Buy? |
| 2026-04-21 | -0.5% | news | StockStory | 3 Russell 2000 Stocks with Warning Signs |
| 2025-05-20 | +0.4% | M&A | Seeking Alpha | Merit Medical Systems acquires Biolife Delaware in $120 million deal |
| 2025-05-20 | +0.4% | legal | SEC EDGAR | MMSI 8-K: 1.01, 2.02, 7.01 (SEC Filing) |
| 2024-09-18 | +0.3% | legal | SEC EDGAR | MMSI 8-K: 1.01, 2.02, 7.01 (SEC Filing) |
| 2026-04-05 | -0.3% | news | Simply Wall St. | Is It Time To Reassess Merit Medical Systems (MMSI) After Its Recent Share Price Slide |
| 2024-12-19 | +0.3% | legal | SEC EDGAR | MMSI 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-24 | -0.2% | news | Stock Titan | New back-pain treatment will reach Medtronic customers later this year - Stock Titan |
| 2024-07-01 | -0.2% | legal | SEC EDGAR | MMSI 8-K: 1.01, 2.02, 7.01 (SEC Filing) |
| 2024-11-01 | +0.2% | legal | SEC EDGAR | MMSI 8-K: 8.01 and (SEC Filing) |
| 2021-04-29 | -0.2% | legal | SEC EDGAR | MMSI 8-K: 2.02, 7.01 (SEC Filing) |
| 2026-03-17 | -0.2% | news | Seeking Alpha | Most oversold mid-cap healthcare stocks on Wall Street amid Middle East disruptions |
| 2025-04-25 | +0.1% | earnings | Seeking Alpha | Merit Medical outlines 2025 revenue growth of up to 10.2% despite tariff challenges |
| 2025-04-25 | +0.1% | earnings | Seeking Alpha | Merit Medical Systems, Inc. (MMSI) Q1 2025 Earnings Call Transcript |
| 2022-11-02 | -0.0% | legal | SEC EDGAR | MMSI 8-K: 8.01 and (SEC Filing) |